Navigation Links
Anastrozole Is A More Effective Cancer Drug

The NHS of the UK has come under increased pressure from charities for making it possible to increase access to a new breast cancer drug which is better than tamoxifen//. Women suffering from the early stages of the disease are treated with tamoxifen. If the women who were treated with tamoxifen for two years were to switch over to anastrozole, one of the new drugs, they are more likely to be alive after a period of two and a half years, according to the research.

In the case of the patients who had switched drugs, the deaths had gone down by 29%. The study was conducted on over 4,000 women across Italy, Germany, and Australia. The deaths among the 2,009 women who changed over to anastrozole was 66, while in the case of tamoxifen, it was 90.

AstraZeneca is marketing anastrozole as Arimidex, and this has received the support of the NHS in Scotland. Tamoxifen administered over 5 years after initial surgery brought down the recurrence of breast cancer by 50%, and administering anastrozole reduces it by a further 26%.

In the UK alone as many as 32,000 postmenopausal women are diagnosed with breast cancer every year, and as three quarters of the tumors are due to sex hormone oestrogen, they are ideal for the new treatment. Arimidex belongs to the aromotase inhibitors class of drugs which prevents the further development of oestrogen.

The treatment costs £68 per month, and it is very much more expensive than tamoxifen. Aromatase inhibitors prevent estrogen and also do not increase the possibilities of endometrial cancer and blood clots. The three brands of this medicine are Novartis Pharmaceuticals’ Femara, Pfizer Inc.’s Aromasin and AstraZeneca PLC’s Arimidex
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... January 18, 2017 , ... The VA Maryland ... collaborating on a research project focused on multiple sclerosis (MS). Led by Christopher ... nanotechnology to control the disease without compromising normal immune function that often occurs ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... pleased to announce that their Vice President of Franchise Development, Paula Turner Pizarro, ... This award-winning business program, which features the insights of top business leaders from ...
(Date:1/18/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent Biologics ... at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. , ...
(Date:1/18/2017)... ... , ... Floundering on New Year’s resolutions? Need an excuse to get back ... The U.S. Apple Association agrees and recommends starting each day with apples, a ... heart disease. , The U.S. Apple Association – which represents apple growers and producers ...
(Date:1/17/2017)... ... 2017 , ... For breast cancer clinicians and researchers who were unable to ... more intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th ... Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... HARRISBURG, Pa. , Jan. 17, 2017 ... Drug and Alcohol Programs Secretary Gary Tennis ... with carfentanil, following two recent overdose deaths from the ... "Carfentanil is intended to sedate large animals ... potentially kill anyone who comes into contact with it," ...
(Date:1/17/2017)... 2017 EU5 Glucose Monitoring Market Outlook to ... Glucose Monitoring Market Outlook to 2022", provides key market ... provides value, in millions of US dollars, volume (in ... Blood Glucose Meters, Blood Glucose Test Strips and Lancets. ... shares data for each of these market segements, and ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... USD 8.02 billion by 2021 from USD 6.35 billion ... major factors driving the growth of this market are ... increasing demand for minimally invasive surgeries. The ... type, procedure, application, and region. On the basis of ...
Breaking Medicine Technology: